The central parity of RMB against the US dollar was reported at 7.1876, down by 22 points; The median price of the previous trading day was 7.1854, the official closing price of the previous trading day was 7.2630, and it closed at 7.2700 last night.The Philippine side's provocation and China's counter-measures will be one step stronger. The Philippine Coast Guard said that China has recently launched "aggressive actions" against Philippine fishing boats heading for the reef. Senior Colonel Wu Qian, director of the Information Bureau of the Ministry of National Defense and spokesman of the Ministry of National Defense, said today that the Philippine side likes to take a boat full of journalists wherever it goes, whether it is sailing or shipping, but the key is not to see who has more journalists, but to see who is more reasonable and legal. China Nansha Islands and Huangyan Island have never been included in the territory of the Philippines, which is determined by a series of international treaties. The Philippines is well aware of this. China's attitude is clear and definite: one point for provocation and one step for counter-attack; If you are stubborn, you will be with me to the end.Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.
The total output of automobiles in Shenzhen is expected to exceed 2.8 million vehicles this year. Last year, Shenzhen ranked among the "First City of New Energy Vehicles in China" with an output of 1.733 million vehicles. This year, the total output is expected to exceed 2.8 million vehicles, and it is expected to win the title of "First City of Automobile in China" again. (released by Shenzhen)The net outflow of the main market exceeded 10 billion.Treasury bond futures opened, with 30-year main contracts rising by 0.48%, 10-year main contracts rising by 0.36%, 5-year main contracts rising by 0.25% and 2-year main contracts rising by 0.05%.
Industrial Securities: The valuation of insurance stocks is in a relatively reasonable position. The Industrial Securities Research Report pointed out that we should continue to be optimistic about the insurance sector and focus on the targets with better performance stability and stronger dividend insurance sales ability. At present, the valuation of insurance stocks is in a relatively reasonable position, but as a strong beta plate, if the equity market further picks up, it may also perform well. There are three catalytic points for the further opening of the subsequent valuation space: first, the long-term interest rate and the performance of the equity market; Second, the adjustment and optimization process of the asset structure of insurance enterprises; The third is the sales situation of dividend insurance. In particular, dividend insurance sales may exceed expectations, and if verified, it will become an important support for opening up the repair space of insurance valuation. Suggested attention: China Ping An, China Pacific Insurance, New China Life Insurance, etc.Zheshang Securities: It does not rule out the possibility of lowering the RRR and cutting interest rates at the same time before the end of the year. Zheshang Securities research report said that this central economic work conference went further on the basis of the previous Politburo meeting, and clearly put forward "timely RRR reduction and interest rate reduction". Combined with the central bank's statement on the RRR reduction space in late September, it is expected that there will be a 50-basis-point RRR reduction before the end of the year, which will greatly promote interest rate reduction in the first quarter of next year, and even does not rule out the possibility of simultaneous RRR reduction and interest rate reduction before the end of the year. We are optimistic that the equity market and the bond market will step out of the double bull market in the process of gradual policy development.Pengyue Automobile Development Co., Ltd., a subsidiary of Tucki, was forced to enforce 680,000 yuan. According to the risk information of Tianyan, recently, Guangzhou Pengyue Automobile Development Co., Ltd. and Hunan Chunqiu Engineering Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 684,000 yuan, involving construction contract disputes. The enforcement court is Tianhe District People's Court of Guangzhou. Guangzhou Pengyue Automobile Development Co., Ltd. was established in August 2021, with the legal representative of Zhao Dawu and the registered capital of 1.88 billion RMB. Its business scope includes auto parts retail, tire sales, investment activities with its own funds, electric vehicle charging infrastructure operation, industrial design service and motor vehicle charging sales, etc. It is wholly owned by Guangzhou Xpeng Motors Technology Co., Ltd.